Anticoagulation during pregnancy in patients with heart valve diseases, valve prostheses, thrombosis or atrial fibrillation - Fetal risk versus maternal thromboemboli;Antikoagulation in graviditate und post partum bei vitien, thrombosen oder vorhofflimmern: Fötale bedrohung versus maternelle thromboembolie

Zeitschrift fur Kardiologie

Volumn 90, Issue SUPPL. 4, 2001, Pages 49-56

  Gohlke Barwolf Ch ^a  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Anticoagulation; Heparin; Mechanical valve prostheses; Pregnancy; Thromboemboli

Indexed keywords

HEPARIN; WARFARIN;

ARTICLE; BLEEDING; DRUG EFFICACY; DRUG SAFETY; EMBRYOPATHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART VALVE REPLACEMENT; HIGH RISK PREGNANCY; HUMAN; MATERNAL MORTALITY; PREGNANCY COMPLICATION; THROMBOEMBOLISM; TREATMENT INDICATION; VALVULAR HEART DISEASE;

ANTICOAGULANTS; ATRIAL FIBRILLATION; BLOOD COAGULATION TESTS; FEMALE; HEART VALVE DISEASES; HEPARIN; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PUERPERAL DISORDERS; THROMBOEMBOLISM;

EID: 0035028675     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. AREVA multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves
2. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry
3. Cardiac valve prostheses, anticoagulation and pregnancy
4. Experience with patient self-management of oral anticoagulation
5. Haemostasis and coagulation disorders in pregnancy
6. ACC/AHA Guidelines for the management of patients with valvular heart disease
7. Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy
8. Guidelines on oral anticoagulation, 3rd edn.
9. Anticoagulation of pregnant women with mechanical heart valves. A systematic review of the literature
10. Pregnancy in patients with prosthetic heart valves: An experience with 45 pregnancies
11. Heparin-induced thrombocytopenia associated with platelet aggregating antibodies and arterial thrombosis
12. Coumarin anticoagulation during pregnancy in patients with mechanical valve prostheses
13. Pregnancy through a prosthetic heart valve
14. Management of thromboembolic disease associated with pregnancy
15. Anticoagulation of women with prosthetic heart valves during pregnancy
16. Use of antithrombotic agents during pregnancy
17. Guidelines for prevention of thromboembolic events in valvular heart disease
18. Empfehlungen zur thromboembolieprophylaxe bei herzklappenerkrankungen der working group on valvular heart disease
19. Thrombosis in pregnancy: Maternal and fetal issues
20. Maternal and fetal sequelae of anticoagulation during pregnancy
21. Pregnancy and prosthetic heart valves: A French cooperative retrospective study of 155 cases
22. Collapse and massive pulmonary edema secondary to thrombosis of a mitral mechanical heart valve prosthesis during LMWH therapy
23. Pregnant women with artificial heart valves
24. LMWH for thromboprophylaxis during pregnancy in two patients with mechanical heart valve replacement
25. Anticoagulation in pregnancy
26. Is warfarin sodium contraindicated in the lactating mother
27. Anticoagulation in pregnant women with mechanical heart valve prostheses
28. Anticoagulant therapy of pregnant patients with prosthetic heart valves: Rationale for a clinical trial of low molecular weight heparin
29. Low molecular weight heparin for obstetric thromboprophylaxis: Experience of sixty-nine pregnancies in sixty-one women at high risk
30. Anticoagulants in pregnancy
31. Low molecular weight heparin novo (LHN-1) does not cross the placenta during the second trimester of pregnancy
32. Mechanism of bone and cartilage maldevelopment in the warfarin embryopathy
33. Pregnancy in patients with prosthetic cardiac valves-A 10 year experience
34. Congenital malformations associated with administration of oral anticoagulants during pregnancy
35. Comparison of low molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis
36. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses
37. A structured teaching and self-management program for patients receiving oral anticoagulation: A randomised controlled trial
38. Outcome of pregnancy in women with valve prostheses
39. Chondrodysplasia punctata and maternal warfarin use during pregnany
40. The use of low molecular weight heparin for thromboprophylaxis in pregnancy
41. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves
42. Heparin-induced thrombocytopenia in patients treated with low-molecular weight heparin or unfractionated heparin